市場調查報告書

尋常型天皰瘡(PV) - 流行病學的預測(2027年)

Pemphigus Vulgaris (PV) - Epidemiology Forecast - 2030

出版商 DelveInsight Business Research LLP 商品編碼 629050
出版日期 內容資訊 英文 100 Pages
商品交期: 最快1-2個工作天內
價格
尋常型天皰瘡(PV) - 流行病學的預測(2027年) Pemphigus Vulgaris (PV) - Epidemiology Forecast - 2030
出版日期: 2020年03月01日內容資訊: 英文 100 Pages
簡介

主要7個國家(美國,英國,德國,法國,義大利,西班牙,日本)的尋常型天皰瘡(PV)的總患病數2016年估計有6萬2,747人。

本報告提供尋常型天皰瘡(PV)的相關調查,疾病概要,患者背景,主要7個國家尋常型天皰瘡(PV)的患病數、罹患數、可治療的病例數的預測(今後10年份),市場成長機會等總括性彙整。

目錄

第1章 重要洞察

第2章 尋常型天皰瘡(PV):疾病背景和概要

  • 簡介
  • 臨床症狀
  • 病因
  • 症候
  • 病理生理學
  • 診斷
    • 國際專家小組的推薦事項

第3章 流行病學和患者人口

  • 主要的觀察
  • 病定義
  • 患者人口與預測參數
  • 主要7個國家尋常型天皰瘡(PV)的患病數
  • 主要7個國家尋常型天皰瘡(PV)的患病數:各重症度

第4章 尋常型天皰瘡(PV)的流行病學:各國

  • 美國
    • 尋常型天皰瘡(PV)的患病數
    • 尋常型天皰瘡(PV)的患病數:各重症度
    • 尋常型天皰瘡(PV)的罹患數
    • 治療可能的尋常型天皰瘡(PV)的病例數
  • 德國
    • 尋常型天皰瘡(PV)的患病數
    • 尋常型天皰瘡(PV)的患病數:各重症度
    • 尋常型天皰瘡(PV)的罹患數
    • 治療可能的尋常型天皰瘡(PV)的病例數
  • 法國
    • 尋常型天皰瘡(PV)的患病數
    • 尋常型天皰瘡(PV)的患病數:各重症度
    • 尋常型天皰瘡(PV)的罹患數
    • 治療可能的尋常型天皰瘡(PV)的病例數
  • 義大利
    • 尋常型天皰瘡(PV)的患病數
    • 尋常型天皰瘡(PV)的患病數:各重症度
    • 尋常型天皰瘡(PV)的罹患數
    • 治療可能的尋常型天皰瘡(PV)的病例數
  • 西班牙
    • 尋常型天皰瘡(PV)的患病數
    • 尋常型天皰瘡(PV)的患病數:各重症度
    • 尋常型天皰瘡(PV)的罹患數
    • 治療可能的尋常型天皰瘡(PV)的病例數
  • 英國
    • 尋常型天皰瘡(PV)的患病數
    • 尋常型天皰瘡(PV)的患病數:各重症度
    • 尋常型天皰瘡(PV)的罹患數
    • 治療可能的尋常型天皰瘡(PV)的病例數
  • 日本
    • 尋常型天皰瘡(PV)的患病數
    • 尋常型天皰瘡(PV)的患病數:各重症度
    • 尋常型天皰瘡(PV)的罹患數
    • 治療可能的尋常型天皰瘡(PV)的病例數

第5章 附錄

第6章 調查手法

  • 資訊來源

第7章 DelveInsight的服務內容

第8章 免責聲明

第9章 關於DelveInsight

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: DIEI0940

DelveInsight's 'Pemphigus Vulgaris (PV) - Epidemiology Forecast to 2030' report delivers an in-depth understanding of the disease, historical and forecasted Pemphigus Vulgaris (PV) epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.

Geographies Covered

  • The United States
  • EU5 (Germany, France, Italy, Spain, and the United Kingdom)
  • Japan

Study Period: 2017-2030

Pemphigus Vulgaris (PV) Understanding

The DelveInsight Pemphigus Vulgaris (PV) epidemiology report gives a thorough understanding of the Pemphigus Vulgaris (PV) by including details such as disease definition, symptoms, causes, pathophysiology, and diagnosis. It also provides treatment algorithms and treatment guidelines for Pemphigus Vulgaris (PV) in the US, Europe, and Japan. The report covers the detailed information of the Pemphigus Vulgaris (PV) epidemiology scenario in seven major countries (US, EU5, and Japan).

Pemphigus Vulgaris (PV) Epidemiology Perspective by DelveInsight

The Pemphigus Vulgaris (PV) epidemiology division provides insights about historical and current patient pool and forecasted trend for every seven major countries. The Pemphigus Vulgaris (PV) epidemiology data are studied through all possible division to give a better understanding of the Disease scenario in 7MM. The Pemphigus Vulgaris (PV) epidemiology segment covers the epidemiology data in the US, EU5 countries (Germany, Spain, Italy, France, and the UK), and Japan from 2017 to 2030. It also helps to recognize the causes of current and forecasted trends by exploring numerous studies, survey reports and views of key opinion leaders.

Pemphigus Vulgaris (PV) Detailed Epidemiology Segmentation

The Pemphigus Vulgaris (PV) epidemiology covered in the report provides historical as well as forecasted Pemphigus Vulgaris (PV) epidemiology scenario in the 7MM covering the United States, EU5 countries (Germany, Spain, Italy, France, and the United Kingdom) and Japan from 2017 to 2030.

The DelveInsight Pemphigus Vulgaris (PV) report also provides the epidemiology trends observed in the 7MM during the study period, along with the assumptions undertaken. The calculated data are presented with relevant tables and graphs to give a clear view of the epidemiology at first sight.

Scope of the Report

  • The Pemphigus Vulgaris (PV) report covers a detailed overview explaining its causes, symptoms, classification, pathophysiology, diagnosis and treatment patterns
  • The Pemphigus Vulgaris (PV) Epidemiology Report and Model provide an overview of the risk factors and global trends of Pemphigus Vulgaris (PV) in the seven major markets (7MM:US, France, Germany, Italy, Spain, UK, and Japan)
  • The report provides insight about the historical and forecasted patient pool of Pemphigus Vulgaris (PV) in seven major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK), and Japan
  • The report helps to recognize the growth opportunities in the 7MM with respect to the patient population
  • The report assesses the disease risk and burden and highlights the unmet needs of Pemphigus Vulgaris (PV)
  • The report provides the segmentation of the Pemphigus Vulgaris (PV) epidemiology

Report Highlights

  • 11-Year Forecast of Pemphigus Vulgaris (PV) epidemiology
  • 7MM Coverage
  • Total Cases of Pemphigus Vulgaris (PV)
  • Total Cases of Pemphigus Vulgaris (PV) according to segmentation
  • Diagnosed cases of Pemphigus Vulgaris (PV)

KOL- Views

We interview, KOLs and SME's opinion through primary research to fill the data gaps and validate our secondary research. The opinion helps to understand the total patient population and current treatment pattern. This will support the clients in potential upcoming novel treatment by identifying the overall scenario of the indications.

Key Questions Answered

  • What will be the growth opportunities in the 7MM with respect to the patient population pertaining to Pemphigus Vulgaris (PV)?
  • What are the key findings pertaining to the Pemphigus Vulgaris (PV) epidemiology across 7MM and which country will have the highest number of patients during the forecast period (2017-2030)?
  • What would be the total number of patients of Pemphigus Vulgaris (PV) across the 7MM during the forecast period (2017-2030)?
  • Among the EU5 countries, which country will have the highest number of patients during the forecast period (2017-2030)?
  • At what CAGR the patient population is expected to grow in 7MM during the forecast period (2017-2030)?
  • What is the disease risk, burden and unmet needs of the Pemphigus Vulgaris (PV)?
  • What are the currently available treatments of Pemphigus Vulgaris (PV)?

Reasons to buy

  • The Pemphigus Vulgaris (PV) Epidemiology report will allow the user to -
  • Develop business strategies by understanding the trends shaping and driving the global Pemphigus Vulgaris (PV) market
  • Quantify patient populations in the global Pemphigus Vulgaris (PV) market to improve product design, pricing, and launch plans
  • Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for Pemphigus Vulgaris (PV) therapeutics in each of the markets covered
  • Understand the magnitude of Pemphigus Vulgaris (PV) population by its epidemiology
  • The Pemphigus Vulgaris (PV) Epidemiology Model developed by DelveInsight is easy to navigate, interactive with dashboards, and epidemiology based with transparent and consistent methodologies. Moreover, the model supports data presented in the report and showcases disease trends over 11-year forecast period using reputable sources

Key Assessments

  • Patient Segmentation
  • Disease Risk and Burden
  • Risk of disease by the segmentation
  • Factors driving growth in a specific patient population

Table of Contents

1. Key Insights

2. Executive Summary of Pemphigus Vulgaris (PV)

3. Pemphigus Vulgaris (PV): Disease Background and Overview

  • 3.1. Introduction
  • 3.2. Sign and Symptoms
  • 3.3. Pathophysiology
  • 3.4. Risk Factors
  • 3.5. Diagnosis

4. Patient Journey

5. Epidemiology and Patient Population

  • 5.1. Epidemiology Key Findings
  • 5.2. Assumptions and Rationale: 7MM
  • 5.3. Epidemiology Scenario: 7MM
    • 5.3.1. Pemphigus Vulgaris (PV) Epidemiology Scenario in the 7MM (2017- 2030)
  • 5.4. United States Epidemiology
    • 5.4.1. Pemphigus Vulgaris (PV) Epidemiology Scenario in the United States (2017- 2030)
  • 5.5. EU-5 Country-wise Epidemiology
    • 5.5.1. Germany Epidemiology
      • 5.5.1.1. Pemphigus Vulgaris (PV) Epidemiology Scenario in Germany (2017- 2030)
    • 5.5.2. France Epidemiology
      • 5.5.2.1. Pemphigus Vulgaris (PV) Epidemiology Scenario in France (2017- 2030)
    • 5.5.3. Italy Epidemiology
      • 5.5.3.1. Pemphigus Vulgaris (PV) Epidemiology Scenario in Italy (2017- 2030)
    • 5.5.4. Spain Epidemiology
      • 5.5.4.1. Pemphigus Vulgaris (PV) Epidemiology Scenario in Spain (2017- 2030)
    • 5.5.5. United Kingdom Epidemiology
      • 5.5.5.1. Pemphigus Vulgaris (PV) Epidemiology Scenario in the United Kingdom (2017-2030)
  • 5.6. Japan Epidemiology
    • 5.6.1. Pemphigus Vulgaris (PV) Epidemiology Scenario in Japan (2017- 2030)

6. Treatment Algorithm, Current Treatment, and Medical Practices

  • 6.1. Pemphigus Vulgaris (PV) Treatment and Management
  • 6.2. Pemphigus Vulgaris (PV) Treatment Algorithm

7. KOL Views

8. Unmet Needs

9. Appendix

  • 9.1. Bibliography
  • 9.2. Report Methodology

10. DelveInsight Capabilities

11. Disclaimer

12. About DelveInsight

The table of contents is not exhaustive; will be provided in the final report

List of Tables

  • Table 1 Pemphigus Vulgaris (PV) Epidemiology in 7MM (2017-2030)
  • Table 2 Pemphigus Vulgaris (PV) Diagnosed and Treatable Cases in 7MM (2017-2030)
  • Table 3 Pemphigus Vulgaris (PV) Epidemiology in the United States (2017-2030)
  • Table 4 Pemphigus Vulgaris (PV) Diagnosed and Treatable Cases in the United States (2017-2030)
  • Table 5 Pemphigus Vulgaris (PV) Epidemiology in Germany (2017-2030)
  • Table 6 Pemphigus Vulgaris (PV) Diagnosed and Treatable Cases in Germany (2017-2030)
  • Table 7 Pemphigus Vulgaris (PV) Epidemiology in France (2017-2030)
  • Table 8 Pemphigus Vulgaris (PV) Diagnosed and Treatable Cases in France (2017-2030)
  • Table 9 Pemphigus Vulgaris (PV) Epidemiology in Italy (2017-2030)
  • Table 10 Pemphigus Vulgaris (PV) Diagnosed and Treatable Cases in Italy (2017-2030)
  • Table 11 Pemphigus Vulgaris (PV) Epidemiology in Spain (2017-2030)
  • Table 12 Pemphigus Vulgaris (PV) Diagnosed and Treatable Cases in Spain (2017-2030)
  • Table 13 Pemphigus Vulgaris (PV) Epidemiology in the United Kingdom (2017-2030)
  • Table 14 Pemphigus Vulgaris (PV) Diagnosed and Treatable Cases in the United Kingdom (2017-2030)
  • Table 15 Pemphigus Vulgaris (PV) Epidemiology in Japan (2017-2030)
  • Table 16 Pemphigus Vulgaris (PV) Diagnosed and Treatable Cases in Japan (2017-2030)

List of Figures

  • Figure 1 Pemphigus Vulgaris (PV) Epidemiology in 7MM (2017-2030)
  • Figure 2 Pemphigus Vulgaris (PV) Diagnosed and Treatable Cases in 7MM (2017-2030)
  • Figure 3 Pemphigus Vulgaris (PV) Epidemiology in the United States (2017-2030)
  • Figure 4 Pemphigus Vulgaris (PV) Diagnosed and Treatable Cases in the United States (2017-2030)
  • Figure 5 Pemphigus Vulgaris (PV) Epidemiology in Germany (2017-2030)
  • Figure 6 Pemphigus Vulgaris (PV) Diagnosed and Treatable Cases in Germany (2017-2030)
  • Figure 7 Pemphigus Vulgaris (PV) Epidemiology in France (2017-2030)
  • Figure 8 Pemphigus Vulgaris (PV) Diagnosed and Treatable Cases in France (2017-2030)
  • Figure 9 Pemphigus Vulgaris (PV) Epidemiology in Italy (2017-2030)
  • Figure 10 Pemphigus Vulgaris (PV) Diagnosed and Treatable Cases in Italy (2017-2030)
  • Figure 11 Pemphigus Vulgaris (PV) Epidemiology in Spain (2017-2030)
  • Figure 12 Pemphigus Vulgaris (PV) Diagnosed and Treatable Cases in Spain (2017-2030)
  • Figure 13 Pemphigus Vulgaris (PV) Epidemiology in the United Kingdom (2017-2030)
  • Figure 14 Pemphigus Vulgaris (PV) Diagnosed and Treatable Cases in the United Kingdom (2017-2030)
  • Figure 15 Pemphigus Vulgaris (PV) Epidemiology in Japan (2017-2030)
  • Figure 16 Pemphigus Vulgaris (PV) Diagnosed and Treatable Cases in Japan (2017-2030)

The table of contents is not exhaustive; will be provided in the final report